SMTL ID : 6wto.1

Human JAK2 JH1 domain in complex with Baricitinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.74 Å

Oligo State

monomer

Ligands

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: F.186, P.225, M.229 No protein-ligand interaction detected (PLIP) EDO.2: 3 residues within 4Å: Chain A: K.236, M.240, H.244 No protein-ligand interaction detected (PLIP)

1 x 3JW: Baricitinib(Non-covalent)

3JW.3: 18 residues within 4Å: Chain A: L.22, G.23, K.24, G.28, S.29, V.30, A.47, K.49, V.78, M.96, E.97, Y.98, L.99, R.147, N.148, L.150, G.160, D.161 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.150, A:L.150 Hydrogen bonds: A:V.30, A:E.97, A:L.99 Water bridges: A:D.161 Salt bridges: A:D.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chang, Y. et al., Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia. Blood (2021)

Release Date

2021-05-05

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence